Arava - An Improved Drug? |
| A recent study has found that only 15% of new drugs approved in the last decade were novel chemicals that the FDA deemed a significant improvement over older drugs. It is not just Arava liver failure that is the concern, but of lymphoma, hypertension, and other problems have also been reported. |
|
Dangers of Arava Arava is dangerous, not just because of the life threatening and serious Arava side effects associated to the rheumatoid arthritis drug, but because the inability to predicts which patients are at risk and the short amount of time it takes for the drug to affect someone. In six months Arava patients have suffered from the dangerous side effects associated to the drug and even when discontinuing the rheumatoid arthritis drug treatment patients are still at risk because it remains within the body as it slowly dissipates. Rheumatoid arthritis affects around 2 million Americans, typically affecting adults between the ages of 25-50. If you have taken Arava and would like more information due to
the serious Arava
side effects that you have, or still are, experiencing, please
CONTACT
US to learn more. |
|
Arava is especially dangerous due to the amount of time the drug remains in the body after discontinuing its use, so the risk of harming an unborn baby can still be great. click here to read more » |
|
A recent study has found that only 15% of new drugs approved in the last decade were novel chemicals that the FDA deemed a significant improvement over older drugs. click here to read more » |
Arava Patient ActionReporting Arava Adverse Effects to the FDA »
Your health care provider or the FDA online reporting form
that allows consumers to notify the FDA of important and useful
information regarding patient safety. If you have taken Arava and
would like more information due to the serious Arava
side effects that you have, or still are, experiencing, please
contact
us to learn more. You may be eligible to file a claim for the
injuries and serious Arava side effects you have sustained as a
result of the rheumatoid arthritis drug that has been linked to
cases of liver failure and other conditions.
|
|
|
|
Arava (leflunomide) manufacturer was sent a letter from the Department of Health and Human Services notifying them that The Division of Drug Marketing, Advertising and Communications reviewed their submissions and found they had violated the Federal Food, Drug, and Cosmetic Act. The FDA had identified violations in the following Arava materials:
|
|
| top of page |
